For ovarian cancer, current biomarkers like carbohydrate antigen 125 (CA125) and human epididymis protein 4 (HE4) suffer from low specificity and sensitivity, leading to high false-positive rates [7]. Here, WFDC2 is linked to ovarian carcinoma.